Ideal Cures expands global reach with a presence in America

Appoints Kamlesh Oza as President – Global Business Development

Ideal Cures, an India-based manufacturer of pharmaceutical coatings and excipients for solid oral dosage forms, has opened an office in the US and has appointed Kamlesh Oza as President – Global Business Development.

The firm says the new US office will augment its global reach from an established network in Asia and Europe to the Americas.

Ideal Cures currently has three EXCiPACT certified cGMP manufacturing plants in India, in addition to offices in India, Italy, Spain, Turkey and Israel.

Oza has held various positions at Colorcon in a career of more than 20 years as Managing Director for Colorcon South Asia, General Manager for Film Coatings Globally, General Manager for Brand Enhancement Services and Director of Global Accounts.

In his new role, Oza will start an application lab and manufacturing plant in the US and develop a team of professionals, portfolios and sales strategies.

You may also like

Ingredients

Ideal Cures becomes first Indian company to receive EXCiPACT certification

Sites at Jammu and Khambhat, India, manufacture pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard
Ingredients

FrieslandCampina Ingredients debuts consumer-driven concepts at Vitafoods Europe

The company will exhibit its omega-3 ingredient, as well as its active gut health solution
Manufacturing

CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery

The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
Ingredients

Therapeutic: acoramidis for transthyretin amyloid cardiomyopathy

Transthyretin amyloid cardiomyopathy (ATTR-CM) is a rare progressive disease that results from genetic mutations or ageing; misfolded TTR protein accumulates as amyloid fibrils in the myocardium
Ingredients

Therapeutic: lutikizumab for hidradenitis suppurativa

Hidradenitis suppurativa (HS) — also known as acne inversa — is a chronic, recurrent and progressive inflammatory disease that leads to irreversible skin damage and disability
Ingredients

Olon: celebrating 10 years of daptomycin and doubled production capacity

Olon's Daptomycin celebrates its 10th anniversary, and in the very year that marks the first decade of production of this first in a new class of antibiotics that represented a breakthrough in the treatment of skin infections, the leading API supplier group announces the doubling of its production to meet and exceed global demand for the active ingredient
Ingredients

Rousselot announces access to pure gelatins through BIO INX

Research and technical grade gelatins are now available for online purchase in Canada, Europe, South Korea and the US
Subscribe now